357
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Does the Montreal Cognitive Assessment (MoCA) identify cognitive impairment profiles in Parkinson’s disease? An exploratory study

, ORCID Icon, &

References

  • Aarsland, D. (2016). Cognitive impairment in Parkinson’s disease and dementia with Lewy bodies. Parkinsonism & Related Disorders, 22, S144–S148. https://doi.org/10.1016/j.parkreldis.2015.09.034
  • Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews. Disease Primers, 7(1), 47. https://doi.org/10.1038/s41572-021-00280-3
  • Aarsland, D., & Kurz, M. W. (2010). The epidemiology of dementia associated with Parkinson’s disease. Brain Pathology (Zurich, Switzerland), 20(3), 633–639. https://doi.org/10.1111/j.1750-3639.2009.00369.x
  • Abós, A., Baggio, H. C., Segura, B., García-Díaz, A. I., Compta, Y., Martí, M. J., Valldeoriola, F., & Junqué, C. (2017). Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning. Scientific Reports, 7, 45347. https://doi.org/10.1038/srep45347
  • Alonso-Recio, L., Martín, P., Carvajal, F., Ruiz, M., & Serrano, J. M. (2013). A holistic analysis of relationships between executive function and memory in Parkinson’s disease. Journal of Clinical and Experimental Neuropsychology, 35(2), 147–159. https://doi.org/10.1080/13803395.2012.758240
  • Alonso-Recio, L., Martín-Plasencia, P., Ruiz, M., & Serrano, J. M. (2018). Differences in cognitive performance in nondemented Parkinson’s disease: A latent profile analysis of cognitive subtypes. Journal of Clinical and Experimental Neuropsychology, 40(8), 777–789. https://doi.org/10.1080/13803395.2018.1432570
  • Aracil-Bolaños, I., Sampedro, F., Marín-Lahoz, J., Horta-Barba, A., Martínez-Horta, S., Botí, M., Pérez-Pérez, J., Bejr-Kasem, H., Pascual-Sedano, B., Campolongo, A., Izquierdo, C., Gironell, A., Gómez-Ansón, B., Kulisevsky, J., & Pagonabarraga, J. (2019). A divergent breakdown of neurocognitive networks in Parkinson’s Disease mild cognitive impairment. Human Brain Mapping, 40(11), 3233–3242. https://doi.org/10.1002/hbm.24593
  • Baiano, C., Barone, P., Trojano, L., & Santangelo, G. (2020). Prevalence and clinical aspects of mild cognitive impairment in Parkinson’s disease: A meta-analysis. Movement Disorders: Official Journal of the Movement Disorder Society, 35(1), 45–54. https://doi.org/10.1002/mds.27902
  • Benedet, M., & Alejandre, M. (1998). Test de aprendizaje verbal España-Complutense (TAVEC). TEA.
  • Benton, A., & Hamsher, K. S. (1989). Multilingual aphasia examination. Iowa City.
  • Benton, A., Hannay, H., & Varney, N. (1975). Visual perception of line direction in patients with unilateral brain disease. Neurology, 25(10), 907–910. https://doi.org/10.1212/wnl.25.10.907
  • Bezdicek, O., Ballarini, T., Růžička, F., Roth, J., Mueller, K., Jech, R., & Schroeter, M. L. (2018). Mild cognitive impairment disrupts attention network connectivity in Parkinson’s disease: A combined multimodal MRI and meta-analytical study. Neuropsychologia, 112, 105–115. https://doi.org/10.1016/j.neuropsychologia.2018.03.011
  • Biundo, R., Weis, L., Bostantjopoulou, S., Stefanova, E., Falup-Pecurariu, C., Kramberger, M. G., Geurtsen, G. J., Antonini, A., Weintraub, D., & Aarsland, D. (2016). MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study. Journal of Neural Transmission, 123(4), 431–438. https://doi.org/10.1007/s00702-016-1517-6
  • Biundo, R., Weis, L., Facchini, S., Formento-Dojot, P., Vallelunga, A., Pilleri, M., & Antonini, A. (2014). Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism & Related Disorders, 20(4), 394–399. https://doi.org/10.1016/j.parkreldis.2014.01.009
  • Broeders, M., de Bie, R. M., Velseboer, D. C., Speelman, J. D., Muslimovic, D., & Schmand, B. (2013). Evolution of mild cognitive impairment in Parkinson disease. Neurology, 81(4), 346–352. https://doi.org/10.1212/WNL.0b013e31829c5c86
  • Bruna, O., Subirana, J., Villalta, V., Virgili, C., & Junqué, C. (2008). Alteraciones neuropsicológicas y de la fluencia verbal en la Enfermedad de Parkinson. Revista de Logopedia, Foniatría y Audiología, 28(1), 8–14. https://doi.org/10.1016/S0214-4603(08)70041-X
  • Camargo, C. H. F., Tolentino, E. D. S., Bronzini, A., Ladeira, M. D. A., Lima, R., Schultz-Pereira, G. L., & Young-Blood, M. R. (2016). Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson’s disease. Dementia & Neuropsychologia, 10(4), 344–350. https://doi.org/10.1590/s1980-5764-2016dn1004015
  • Chaudhary, S., Kumaran, S. S., Kaloiya, G. S., Goyal, V., Sagar, R., Kalaivani, M., Jaganathan, N. R., Mehta, N., & Srivastava, A. (2020). Domain specific cognitive impairment in Parkinson’s patients with mild cognitive impairment. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, 75, 99–105. https://doi.org/10.1016/j.jocn.2020.03.015
  • Chou, K. L., Lenhart, A., Koeppe, R. A., & Bohnen, N. I. (2014). Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: Cognitive and neurochemical correlates. Parkinsonism & Related Disorders, 20(10), 1076–1080. https://doi.org/10.1016/j.parkreldis.2014.07.008
  • Costa, A. S., Reich, A., Fimm, B., Ketteler, S. T., Schulz, J. B., & Reetz, K. (2014). Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 37(1–2), 95–103. https://doi.org/10.1159/000351864
  • Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J., Keenan, R., Wells, S., Porter, R. J., Watts, R., & Anderson, T. J. (2010). The MoCA: Well-suited screen for cognitive impairment in Parkinson disease. Neurology, 75(19), 1717–1725. https://doi.org/10.1212/WNL.0b013e3181fc29c9
  • Devignes, Q., Viard, R., Betrouni, N., Carey, G., Kuchcinski, G., Defebvre, L., Leentjens, A., Lopes, R., & Dujardin, K. (2021). Posterior cortical cognitive deficits are associated with structural brain alterations in mild cognitive impairment in Parkinson’s disease. Frontiers in Aging Neuroscience, 13, 668559. https://doi.org/10.3389/fnagi.2021.668559
  • Donzuso, G., Monastero, R., Cicero, C. E., Luca, A., Mostile, G., Giuliano, L., Baschi, R., Caccamo, M., Gagliardo, C., Palmucci, S., Zappia, M., & Nicoletti, A. (2021). Neuroanatomical changes in early Parkinson’s disease with mild cognitive impairment: A VBM study; the Parkinson’s Disease Cognitive Impairment Study (PaCoS). Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42(9), 3723–3731. https://doi.org/10.1007/s10072-020-05034-9
  • Dujardin, K., Leentjens, A. F., Langlois, C., Moonen, A. J., Duits, A. A., Carette, A. S., & Duhamel, A. (2013). The spectrum of cognitive disorders in Parkinson’s disease: A data-driven approach. Movement Disorders: Official Journal of the Movement Disorder Society, 28(2), 183–189. https://doi.org/10.1002/mds.25311
  • Dujardin, K., Moonen, A. J., Behal, H., Defebvre, L., Duhamel, A., Duits, A. A., Plomhause, L., Tard, C., & Leentjens, A. F. (2015). Cognitive disorders in Parkinson’s disease: Confirmation of a spectrum of severity. Parkinsonism & Related Disorders, 21(11), 1299–1305. https://doi.org/10.1016/j.parkreldis.2015.08.032
  • Fengler, S., Liepelt-Scarfone, I., Brockmann, K., Schäffer, E., Berg, D., & Kalbe, E. (2017). Cognitive changes in prodromal Parkinson’s disease: A review. Movement Disorders: Official Journal of the Movement Disorder Society, 32(12), 1655–1666. https://doi.org/10.1002/mds.27135
  • Filoteo, J. V., Reed, J. D., Litvan, I., & Harrington, D. L. (2014). Volumetric correlates of cognitive functioning in nondemented patients with Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 29(3), 360–367. https://doi.org/10.1002/mds.25633
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6
  • Garcia-Diaz, A. I., Segura, B., Baggio, H. C., Uribe, C., Campabadal, A., Abos, A., Marti, M. J., Valldeoriola, F., Compta, Y., Bargallo, N., & Junque, C. (2018). Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson’s disease: A 4-year follow-up. Parkinsonism & Related Disorders, 46, 62–68. https://doi.org/10.1016/j.parkreldis.2017.11.003
  • Golden, C. J. (1994). Stroop. Test de Colores y Palabras. TEA Ediciones.
  • Goldman, J. G., Holden, S. K., Litvan, I., McKeith, I., Stebbins, G. T., & Taylor, J. P. (2018). Evolution of diagnostic criteria and assessments for Parkinson’s disease mild cognitive impairment. Movement Disorders: Official Journal of the Movement Disorder Society, 33(4), 503–510. https://doi.org/10.1002/mds.27323
  • Gruszka, A., Hampshire, A., Barker, R. A., & Owen, A. M. (2017). Normal aging and Parkinson’s disease are associated with the functional decline of distinct frontal-striatal circuits. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 93, 178–192. https://doi.org/10.1016/j.cortex.2017.05.020
  • Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., & MDS Task Force on the Definition of Parkinson’s Disease (2019). Update of the MDS research criteria for prodromal Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 34(10), 1464–1470. https://doi.org/10.1002/mds.27802
  • Hendershott, T. R., Zhu, D., Llanes, S., & Poston, K. L. (2017). Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson’s disease. Parkinsonism & Related Disorders, 38, 31–34. https://doi.org/10.1016/j.parkreldis.2017.02.008
  • Hendershott, T. R., Zhu, D., Llanes, S., Zabetian, C. P., Quinn, J., Edwards, K. L., Leverenz, J. B., Montine, T., Cholerton, B., & Poston, K. L. (2019). Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 34(2), 285–291. https://doi.org/10.1002/mds.27575
  • Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427–442. https://doi.org/10.1212/wnl.17.5.427
  • Hoops, S., Nazem, S., Siderowf, A., Duda, J., Xie, S., Stern, M., & Weintraub, D. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73(21), 1738–1745. https://doi.org/10.1212/WNL.0b013e3181c34b47
  • Izal, M., Montorio, I., Nuevo, R., Pérez-Rojo, G., & Cabrera, I. (2010). Optimising the diagnostic performance of the Geriatric Depression Scale. Psychiatry Research, 178(1), 142–146. https://doi.org/10.1016/j.psychres.2009.02.018
  • Julayanont, P., & Nasreddine, Z. S. (2017). Montreal Cognitive Assessment (MoCA): Concept and clinical review. In A. J. Larner (Eds.), Cognitive screening instruments (pp. 139–195). Springer. https://doi.org/10.1007/978-3-319-44775-9_7
  • Kalbe, E., Rehberg, S. P., Heber, I., Kronenbuerger, M., Schulz, J. B., Storch, A., Linse, K., Schneider, C., Gräber, S., Liepelt-Scarfone, I., Berg, D., Dams, J., Balzer-Geldsetzer, M., Hilker, R., Oberschmidt, C., Witt, K., Schmidt, N., Mollenhauer, B., Trenkwalder, C., … Dodel, R. (2016). Subtypes of mild cognitive impairment in patients with Parkinson’s disease: Evidence from the LANDSCAPE study. Journal of Neurology, Neurosurgery, and Psychiatry, 87(10), 1099–1105. https://doi.org/10.1136/jnnp-2016-313838
  • Kaplan, E., Goodglass, H., & Weintraub, S. (1983). The Boston naming test: Experimental edition. Lee & Febiger.
  • Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010). Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. The Lancet. Neurology, 9(12), 1200–1213. https://doi.org/10.1016/S1474-4422(10)70212-X
  • Kim, H. M., Nazor, C., Zabetian, C. P., Quinn, J. F., Chung, K. A., Hiller, A. L., Hu, S.-C., Leverenz, J. B., Montine, T. J., Edwards, K. L., & Cholerton, B. (2019). Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures. Clinical Parkinsonism & Related Disorders, 1, 91–97. https://doi.org/10.1016/j.prdoa.2019.08.006
  • Kim, J., Criaud, M., Cho, S. S., Díez-Cirarda, M., Mihaescu, A., Coakeley, S., Ghadery, C., Valli, M., Jacobs, M. F., Houle, S., & Strafella, A. P. (2017). Abnormal intrinsic brain functional network dynamics in Parkinson’s disease. Brain: A Journal of Neurology, 140(11), 2955–2967. https://doi.org/10.1093/brain/awx233
  • Kunst, J., Marecek, R., Klobusiakova, P., Balazova, Z., Anderkova, L., Nemcova-Elfmarkova, N., & Rektorova, I. (2019). Patterns of grey matter atrophy at different stages of Parkinson’s and Alzheimer’s diseases and relation to cognition. Brain Topography, 32(1), 142–160. https://doi.org/10.1007/s10548-018-0675-2
  • Kwak, S., Kim, H., Kim, H., Youm, Y., & Chey, J. (2021). Distributed functional connectivity predicts neuropsychological test performance among older adults. Human Brain Mapping, 42(10), 3305–3325. https://doi.org/10.1002/hbm.25436
  • Lang, S., Hanganu, A., Gan, L. S., Kibreab, M., Auclair-Ouellet, N., Alrazi, T., Ramezani, M., Cheetham, J., Hammer, T., Kathol, I., Sarna, J., & Monchi, O. (2019). Network basis of the dysexecutive and posterior cortical cognitive profiles in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 34(6), 893–902. https://doi.org/10.1002/mds.27674
  • Lawrence, B. J., Gasson, N., & Loftus, A. M. (2016). Prevalence and subtypes of mild cognitive impairment in Parkinson’s Disease. Scientific Reports, 6(1), 33929–33929. https://doi.org/10.1038/srep33929
  • Lévy, R., & Pillon, B. (2006). Troubles cognitifs non démentiels de la maladie de Parkinson [Cognitive disorders in Parkinson’s disease without dementia]. Psychologie & neuropsychiatrie du vieillissement, 4(1), S25–S34. https://doi.org/10.1684/pnv.2006.0005
  • Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., Rodriguez-Oroz, M. C., Tröster, A. I., & Weintraub, D. (2011). MDS Task Force on mild cognitive impairment in Parkinson’s disease: Critical review of PD-MCI. Movement Disorders: Official Journal of the Movement Disorder Society, 26(10), 1814–1824. https://doi.org/10.1002/mds.23823
  • Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A., & Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders: Official Journal of the Movement Disorder Society, 27(3), 349–356. https://doi.org/10.1002/mds.24893
  • Marras, C., Armstrong, M. J., Meaney, C. A., Fox, S., Rothberg, B., Reginold, W., Tang-Wai, D. F., Gill, D., Eslinger, P. J., Zadikoff, C., Kennedy, N., Marshall, F. J., Mapstone, M., Chou, K. L., Persad, C., Litvan, I., Mast, B. T., Gerstenecker, A. T., Weintraub, S., & Duff-Canning, S. (2013). Measuring mild cognitive impairment in patients with Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 28(5), 626–633. https://doi.org/10.1002/mds.25426
  • Martínez-Horta, S., & Kulisevsky, J. (2019). Mild cognitive impairment in Parkinson’s disease. Journal of Neural Transmission (Vienna, Austria: 1996), 126(7), 897–904. https://doi.org/10.1007/s00702-019-02003-1
  • Martínez-Martín, P., Forjaz, M. J., Cubo, E., Frades, B., & de Pedro Cuesta, J., & ELEP Project Members (2006). Global versus factor-related impression of severity in Parkinson’s disease: A new clinimetric index (CISI-PD). Movement Disorders: Official Journal of the Movement Disorder Society, 21(2), 208–214. https://doi.org/10.1002/mds.20697
  • Matías-Guiu, J. A., Valles-Salgado, M., Rognoni, T., Hamre-Gil, F., Moreno-Ramos, T., & Matías-Guiu, J. (2017). Comparative diagnostic accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for screening of Alzheimer disease. Dementia and Geriatric Cognitive Disorders, 43(5–6), 237–246. https://doi.org/10.1159/000469658
  • Mazancova, A. F., Růžička, E., Jech, R., & Bezdicek, O. (2020). Test the best: Classification accuracies of four cognitive rating scales for Parkinson’s disease mild cognitive impairment. Archives of Clinical Neuropsychology, 35(7), 1069–1077. Advance online publication. https://doi.org/10.1093/arclin/acaa039
  • Monastero, R., Cicero, C. E., Baschi, R., Davì, M., Luca, A., Restivo, V., Zangara, C., Fierro, B., Zappia, M., & Nicoletti, A. (2018). Mild cognitive impairment in Parkinson’s disease: The Parkinson’s disease cognitive study (PACOS). Journal of Neurology, 265(5), 1050–1058. https://doi.org/10.1007/s00415-018-8800-4
  • Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
  • Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D. J., Rothwell, J. C., Hallett, M., DeLong, M. R., Marras, C., Tanner, C. M., Ross, G. W., Langston, J. W., … Stoessl, A. J. (2017). Past, present, and future of Parkinson’s disease: A special essay on the 200th anniversary of the shaking palsy. Movement Disorders: Official Journal of the Movement Disorder Society, 32(9), 1264–1310. https://doi.org/10.1002/mds.27115
  • O’Callaghan, C., & Lewis, S. (2017). Cognition in Parkinson’s disease. International Review of Neurobiology, 133, 557–583. https://doi.org/10.1016/bs.irn.2017.05.002
  • Pan, C., Ren, J., Li, L., Li, Y., Xu, J., Xue, C., Hu, G., Yu, M., Chen, Y., Zhang, L., Zhang, W., Hu, X., Sun, Y., Liu, W., & Chen, J. (2021). Differential functional connectivity of insular subdivisions in de novo Parkinson’s disease with mild cognitive impairment. Brain Imaging and Behavior. Advance online publication. https://doi.org/10.1007/s11682-021-00471-2
  • Papagno, C., & Trojano, L. (2018). Cognitive and behavioral disorders in Parkinson’s disease: An update. I: Cognitive impairments. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 39(2), 215–223. https://doi.org/10.1007/s10072-017-3154-8
  • Pfeiffer, H. C., Løkkegaard, A., Zoetmulder, M., Friberg, L., & Werdelin, L. (2014). Cognitive impairment in early-stage non-demented Parkinson’s disease patients. Acta neurologica Scandinavica, 129(5), 307–318. https://doi.org/10.1111/ane.12189
  • Postuma, R. B., & Berg, D. (2017). The new diagnostic criteria for Parkinson’s disease. International Review of Neurobiology, 132, 55–78. https://doi.org/10.1016/bs.irn.2017.01.008
  • Pourzinal, D., Yang, J., Byrne, G. J., O’Sullivan, J. D., Mitchell, L., McMahon, K. L., Copland, D. A., & Dissanayaka, N. N. (2020). Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis. Journal of Neurology, 267(11), 3213–3222. https://doi.org/10.1007/s00415-020-09977-z
  • Rao, S. M., Hammeke, T. A., McQuillen, M. P., Khatri, B. O., & Lloyd, D. (1984). Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology, 41(6), 625–631. https://doi.org/10.1001/archneur.1984.04210080033010
  • Reich, S. G., & Savitt, J. M. (2019). Parkinson’s disease. The Medical Clinics of North America, 103(2), 337–350. https://doi.org/10.1016/j.mcna.2018.10.014
  • Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271–276. https://doi.org/10.2466/pms.1958.8.3.271
  • Rodriguez-Constenla, I., Cabo-López, I., Bellas-Lamas, P., & Cebrián, E. (2010). Trastornos cognitivos y neuropsiquiátricos en la enfermedad de Parkinson [Cognitive and neuropsychiatric disorders in Parkinson’s disease]. Revista de neurologia, 50(2), 33–39. https://doi.org/10.33588/rn.50S02.2009737
  • Saredakis, D., Collins-Praino, L. E., Gutteridge, D. S., Stephan, B., & Keage, H. (2019). Conversion to MCI and dementia in Parkinson’s disease: A systematic review and meta-analysis. Parkinsonism & Related Disorders, 65, 20–31.
  • Skorvanek, M., Goldman, J. G., Jahanshahi, M., Marras, C., Rektorova, I., Schmand, B., van Duijn, E., Goetz, C. G., Weintraub, D., Stebbins, G. T., Martinez-Martin, P., & members of the MDS Rating Scales Review Committee (2018). Global scales for cognitive screening in Parkinson’s disease: Critique and recommendations. Movement Disorders: Official Journal of the Movement Disorder Society, 33(2), 208–218. https://doi.org/10.1002/mds.27233
  • Song, S. K., Lee, J. E., Park, H. J., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2011). The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Movement Disorders, 26(2), 289–296. https://doi.org/10.1002/mds.23477
  • Sulzer, P., Becker, S., Maetzler, W., Kalbe, E., van Nueten, L., Timmers, M., Machetanz, G., Streffer, J., Salvadore, G., Scholz, E., Tkaczynska, Z., Brockmann, K., Berg, D., & Liepelt-Scarfone, I. (2018). Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson’s disease patients. Journal of Neurology, 265(9), 1976–1984. https://doi.org/10.1007/s00415-018-8942-4
  • Suo, X., Lei, D., Li, N., Li, J., Peng, J., Li, W., Yang, J., Qin, K., Kemp, G. J., Peng, R., & Gong, Q. (2021). Topologically convergent and divergent morphological gray matter networks in early-stage Parkinson’s disease with and without mild cognitive impairment. Human Brain Mapping, 42(15), 5101–5112. Advance online publication. https://doi.org/10.1002/hbm.25606
  • Tinaz, S. (2021). Functional connectome in Parkinson’s disease and Parkinsonism. Current Neurology and Neuroscience Reports, 21(6), 24. https://doi.org/10.1007/s11910-021-01111-4
  • Vásquez, K. A., Valverde, E. M., Aguilar, D. V., & Gabarain, H. J. H. (2019). Montreal cognitive assessment scale in patients with Parkinson disease with normal scores in the mini-mental state examination. Dement Neuropsychol, 13(1), 78–81. https://doi.org/10.1590/1980-57642018dn13-010008
  • Wallace, E. R., Segerstrom, S. C., van Horne, C. G., Schmitt, F. A., & Koehl, L. M. (2021). Meta-analysis of cognition in Parkinson’s disease mild cognitive impairment and dementia progression. Neuropsychology Review. https://doi.org/10.1007/s11065-021-09502-7
  • Watson, G. S., & Leverenz, J. B. (2010). Profile of cognitive impairment in Parkinson’s disease. Brain Pathology (Zurich, Switzerland), 20(3), 640–645. https://doi.org/10.1111/j.1750-3639.2010.00373.x
  • Weintraub, D., Tröster, A. I., Marras, C., & Stebbins, G. (2018). Initial cognitive changes in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 33(4), 511–519. https://doi.org/10.1002/mds.27330
  • Wechsler, D. (2004). Escala de memoria de Weschler (WMS-III). TEA Ediciones.
  • Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., & Barker, R. A. (2009). The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain: A Journal of Neurology, 132(Pt 11), 2958–2969. https://doi.org/10.1093/brain/awp245
  • Wolters, A. F., van de Weijer, S., Leentjens, A., Duits, A. A., Jacobs, H., & Kuijf, M. L. (2019). Resting-state fMRI in Parkinson’s disease patients with cognitive impairment: A meta-analysis. Parkinsonism & Related Disorders, 62, 16–27. https://doi.org/10.1016/j.parkreldis.2018.12.016
  • Zadikoff, C., Fox, S. H., Tang-Wai, D. F., Thomsen, T., de Bie, R. M., Wadia, P., Miyasaki, J., Duff-Canning, S., Lang, A. E., & Marras, C. (2008). A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson’s disease. Movement Disorders, 23(2), 297–299. https://doi.org/10.1002/mds.21837

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.